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Abstract
Background: Carbon nanotubes (CNT) and carbon nanofibers (CNF) are allotropes of carbon featuring fibrous
morphology. The dimensions and high aspect ratio of CNT and CNF have prompted the comparison with naturally
occurring asbestos fibers which are known to be extremely pathogenic. While the toxicity and hazardous
outcomes elicited by airborne exposure to single-walled CNT or asbestos have been widely reported, very limited
data are currently available describing adverse effects of respirable CNF.
Results: Here, we assessed pulmonary inflammation, fibrosis, oxidative stress markers and systemic immune
responses to respirable CNF in comparison to single-walled CNT (SWCNT) and asbestos. Pulmonary inflammatory
and fibrogenic responses to CNF, SWCNT and asbestos varied depending upon the agglomeration state of the
particles/fibers. Foci of granulomatous lesions and collagen deposition were associated with dense particle-like
SWCNT agglomerates, while no granuloma formation was found following exposure to fiber-like CNF or asbestos.
The average thickness of the alveolar connective tissue - a marker of interstitial fibrosis - was increased 28 days
post SWCNT, CNF or asbestos exposure. Exposure to SWCNT, CNF or asbestos resulted in oxidative stress evidenced
by accumulations of 4-HNE and carbonylated proteins in the lung tissues. Additionally, local inflammatory and
fibrogenic responses were accompanied by modified systemic immunity, as documented by decreased
proliferation of splenic T cells ex vivo on day 28 post exposure. The accuracies of assessments of effective surface
area for asbestos, SWCNT and CNF (based on geometrical analysis of their agglomeration) versus estimates of mass
dose and number of particles were compared as predictors of toxicological outcomes.
Conclusions: We provide evidence that effective surface area along with mass dose rather than specific surface
area or particle number are significantly correlated with toxicological responses to carbonaceous fibrous
nanoparticles. Therefore, they could be useful dose metrics for risk assessment and management.
Background
Carbon nanotubes (CNT), including single-walled
(SWCNT), double-, and multi-walled (MWCNT), and car-
bon nanofibers (CNF) are allotropes of carbon featuring
fibrous morphology. SWCNT (typically 0.4 - 3 nm in
diameter) are composed of a single cylindrical sheet of
graphene, MWCNT (2-200 nm in diameter) consist of
several concentric, coaxial rolled up graphene sheets [1,2].
In contrast to CNT, CNF represent a less perfect graphene
sheet arrangement, with layers of graphene stacked at an
angle to the fiber axis. CNF, formed from graphene nano-
cones or “cups” and sometimes referred to as “stacked-cup
carbon nanotubes”, are strong flexible filaments ranging
from 70-200 nm in diameter and 10 μm - 100 μmi n
length. They are advantageous for a broad variety of appli-
cations, such as nanocomposites and biomedical devices.
Due to their cost-effectiveness, the commercial use of
CNF has grown exponentially [3,4]. CNT and CNF are
elongated structures with a high aspect ratio (up to
1:1000, length/width) produced predominantly by HiPco,
* Correspondence: ats1@cdc.gov
† Contributed equally
1Pathology and Physiology Research Branch, Health Effects Laboratory
Division, National Institute for Occupational Safety and Health, Morgantown,
WV, USA
Full list of author information is available at the end of the article
Murray et al. Particle and Fibre Toxicology 2012, 9:10
http://www.particleandfibretoxicology.com/content/9/1/10
© 2012 Murray et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.chemical vapor deposition, laser ablation or arc discharge
by employing a variety of catalytic metal particles [5]. The
purity of CNT and CNF depends on the technology used
and on the subsequently applied purification procedures.
There is considerable debate on how morphology, physical
and chemical properties, including size, shape, charge and/
or agglomeration state, are translated to the toxicity of
fibrous nanomaterials (NM). The dimensions and high
aspect ratio of CNT and CNF have driven their compari-
sons with naturally occurring asbestos fibers, which are
known to be extremely pathogenic [6-8]. However, while
the toxicity and hazardous outcomes elicited by airborne
exposure to SWCNT and MWCNT has been widely
reported [9-15], very limited data are currently available
describing the adverse effects of respirable CNF.
Physical dimensions, surface properties and biopersis-
tence are key factors underlying the potential toxicity of
fibrous NM. Their aerodynamic diameter along with par-
ticle dimensions dictates the pattern of deposition within
lungs [16,17]. The primary site for deposition of fibrous
NP is the alveolar region. In the alveolar area, NP are
phagocytosed by macrophages (MF) and cleared via the
mucociliary escalator. While short fibers are efficiently
cleared, the longer ones are retained in the lung thus
causing a persistent lung burden [18,19]. Phagocytosis
targets fibrous NP aiming to break them down. However,
many fibrous NP are chemically resistant and cannot be
readily dissolved in physiological conditions. Repeated
attempts to phagocytose asbestos fibers by MF trigger a
cascade of amplifying events resulting in the generation
of reactive oxygen/nitrogen species (ROS/NOS), release
of inflammatory cytokines and/or chemokines, and leak-
ing of lysosomal enzymes, thus leading to cellular injury
and pulmonary inflammation frequently culminating
with acute pneumonia [18].
Exposure to amphibole or crocidolite asbestos environ-
mentally and/or in the workplace has been strongly asso-
ciated with pulmonary fibrosis, autoimmune diseases and
mesothelioma [20]. In light of recently reported geno-
toxic effects resembling those seen after asbestos expo-
sure, there is a huge debate regarding whether exposure
to fibrous carbon-derived nanomaterials (NM) follow a
similar paradigm [4,21-23].
Because the effects of airborne CNF have not been pre-
viously addressed, we designed a comparative study
assessing pulmonary inflammation, fibrosis, and systemic
i m m u n er e s p o n s e st or e s p i r a b l eC N F ,S W C N T ,a n d
asbestos. Pulmonary outcomes along with innate and sys-
temic immune responses were evaluated at 1, 7, and 28
days post exposure. The obtained data provide evidence
that respirable CNF are quite hazardous, exhibiting simi-
lar pulmonary responses to those seen following SWCNT
and asbestos exposure. While acute pulmonary inflam-
mation and fibrosis induced by CNF and asbestos were
delayed as compared to SWCNT, the systemic immune
response elicited by CNF was akin to that observed for
asbestos. Exposure to CNF and SWCNT was found to
facilitate persistent pulmonary fibrosis along with
immune suppression resembling the effects of asbestos,
which could potentially promote progression of neoplas-
tic lesions and cancer.
Results
Particle characterization
All particles utilized in the current study were charac-
terized by chemical analysis by NMAM #5040 and ICP-
AES. Pyrograf CNF was found to be 98.6% wt. elemental
carbon with iron levels of 1.4% wt. CNF diameters ran-
ged from 80 to 160 nm. A specific surface area (SSA) of
CNF was 35-45 m
2/g (measured by BET). Length
was determined by SEM and found to be approximately
5-30 μm (Figure 1). SWCNT were 99.7% wt. elemental
carbon with 0.23% wt iron. Individual SWCNT had dia-
meters ranging from 1 to 4 nm and were 1-3 μmi n
length. SWCNT were found to have a specific surface
area of 1040 m
2/g. As evidenced by TEM, individual
SWCNT were bundled in ropes with diameters of
~65 nm (Figure 1C, inset). Crocidolite asbestos fibers
lengths were within 2-30 μmr a n g ea n dw i d t ho f
160-800 nm. Asbestos had a surface area of 8.3 m
2/g.
Iron levels in crocidolite asbestos were found to be 18%
wt. In the suspensions of asbestos and CNF utilized in
the current study, a substantial amount of particles/bun-
dles had a conventional fibrous morphology falling
under WHO definition: e.g. length > 5 micrometer, dia-
meter < 3 micrometer (Figure 1E). Individual SWCNT
bundles in our preparations also fit into the fiber defini-
tion; however, they were agglomerated into tertiary
structures, which, of course, no longer possess a fibrous
morphology (Figure 1C).
Calculations of effective surface area of SWCNT and CNF
using geometrical analysis
Geometrical analysis of the surface areas of SWCNT and
CNF agglomerates were conducted as follows. The char-
acterization of SWCNT particles using TEM indicated
that a bundled rope of SWCNT (Figure 1C, inset) has an
average diameter of ~65 nm. It should be noted that the
manufacturer’s specifications for SWCNT had a specific
surface area (SSA) of 1040 m
2/g and diameters ranging
from 1 to 4 nm, significantly lower than what we
observed. This apparent discrepancy in diameters may be
due to the tendency of SWCNT to form bundles because
of Van der Waals interactions. Hence, it becomes impor-
tant to understand, how a bundle with N identical
SWCNT arranged in the form of an agglomerated net-
work (Figure 2A) affects the effective surface area.
Assuming that each SWCNT has an average diameter of
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bundle of diameter ~65 nm will contain a total of ~295
SWCNT arranged in 10 layers with an effective accessible
surface area equivalent to ~31 SWCNT (see Methods).
Therefore, the effective surface area of SWCNT bundles
can be estimated as 138.2 m
2/g (using eq (4): 1315 × (31/
295) m
2/g). Thus, the effective surface area of SWCNT of
diameter ~3 nm decreases from 1040 m
2/g to 138 m
2/g
when it forms SWCNT bundles with a diameter of ~65
nm. Similarly, from the SEM images (Figure 1A), we
determined that CNF particles had an average hollow
core and outer diameters (Figure 2B) of ~53 nm and
~109 nm, respectively. Using equations 5 & 6 (see Meth-
ods), we estimated that CNF particles are made up of
~82 carbon layers, and have an effective surface area of
~21 m
2/g. Based on these calculations, the effective sur-
face area of 40 μgo fS W C N Ta n d1 2 0μgo fC N Fw i l l
correspond to 5.52 × 10
-3 m
2/g and 2.52 × 10
-3 m
2/g. As
a result, the effective surface area of SWCNT and CNF
administered is ~5.8 times and ~2.6 times higher, respec-
tively as compared to asbestos (9.6 × 10
-4 m
2/mouse).
Characterization of pulmonary inflammatory response
In order to evaluate lung injury and inflammatory
responses to CNF particles, comparing to those
observed in SWCNT and asbestos, cell differential and
total BAL cell counts, permeability of the lung epithe-
lium (protein levels), and cell damage (LDH release)
were determined 1, 7, and 28 days following pharyn-
geal aspiration of nanoparticles/fibers in C57BL/6
mice. Analysis of the pulmonary inflammatory
response following CNF and SWCNT exposure indi-
cated an accumulation of PMNs (150 and 700 fold vs
control, respectively, Figure 3A) on day 1 followed by
an influx of AMs (Figure 3B) peaking on day 7 (2.0
and 1.6 fold vs control, respectively). In comparison,
exposure to asbestos induced a “delayed” inflammatory
response with maximal PMN influx (675-fold vs con-
trol) occurring on day 7 post exposure. By day 28 post
exposure to CNF, PMNs, and AMs in BAL fluid sub-
stantially decreased; however, the numbers still
remained elevated (25-, and 1.6 fold, respectively) as
compared to control.
Figure 1 Scanning Electron Microscopy images of CNF (A), asbestos (B), SWCNT (C, Inset: TEM showing individual roped SWCNT),
structure numbers per dose (D) and particles size (length) distribution (E) presented as % of total particles.
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increased lung permeability, as evidenced by elevated
total protein in the BAL fluid. CNF exposure (120 μg/
mouse) induced a 1.86-, 1.75-, and 1.14-fold increase in
BAL protein on days 1, 7, and 28 post exposure, respec-
tively (Figure 4A). In comparison, SWCNT (40 μg/
mouse) exposure resulted in a raise in protein up to
3.75, 2.5 and 2.6 folds of control on days 1, 7 and 28,
respectively. Increased lung permeability was also
observed following asbestos exposure with a maximal
2.05-fold increase in protein observed 7 days post expo-
sure (Figure 4A).
The degree of pulmonary cytotoxicity elicited by
SWCNT, CNF or asbestos was assessed by LDH activity
in the BAL fluid recovered from mice. LDH levels were
significantly elevated after exposure to CNF (120 μg/
mouse; 1.8 fold vs control mice) on days 1 and 7 post
exposure (Figure 4B). On day 28 post-CNF, LDH levels
remained significantly (1.5 fold) elevated as compared to
control mice. Similarly, the release of LDH in response
to SWCNT and asbestos followed the same trends.
Overall, SWCNT, CNF, and asbestos were all capable of
inducing acute pulmonary cell damage with the potency
as follows: SWCNT > CNF > asbestos.
Oxidative stress in the lungs
Oxidative damage assessed by levels of 4-hydroxynonenol
(4-HNE) and oxidatively modified proteins (protein car-
bonyls) in the lungs of mice exposed to CNF, SWCNT,
or asbestos is presented at Figure 5. The time course of
4-HNE accumulation in the lungs following CNF aspira-
tion revealed a significant 6 and 4-fold increase (vs. con-
trol) after 1 and 7 days post exposure, respectively
(Figure 5A). On day 28 post exposure, the levels of 4-
HNE in the lungs of CNF exposed mice returned to con-
t r o ll e v e l s .A sc o m p a r e dt oC N F ,S W C N Te x p o s u r e
(40 μg/mouse) induced a more pronounced accumula-
tion of 4-HNE (9.5 and 10.0 fold vs control) on 1 and 7
days post exposure, persisting through day 28 post expo-
sure (6.0 fold vs control). Asbestos exposure did not
induce 4-HNE accumulation in the lungs on days 1 and 7
post exposure; however, a marked increase in amount of
4-HNE (11 fold vs control) was observed 28 days post
exposure (Figure 5A).
Additionally, levels of oxidatively modified proteins, i.e.
protein carbonyls, were evaluated in the lungs following
SWCNT, CNF or asbestos exposure. SWCNT induced
the most significant and sustained increase of protein
carbonyls (4.8, 3.5, 3.5 fold vs control) found 1, 7, and 28
Figure 2 Schematic representation of the SWCNT bundles and CNF. (A) A hexagonal arrangement model of a bundle containing two layers
of SWCNT. The labels dSWCNT and dbundle correspond to the diameters of SWCNT and a bundle of SWCNT, respectively. (B) A model of CNF
showing five carbon layers. The labels dOD, and dHC correspond to the outer and hollow core diameters of CNF, respectively.
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Page 4 of 19Figure 3 Cell profile in BAL fluids of C57BL/6 mice after pharyngeal aspiration with CNF, Crocidolite Asbestos, or SWCNT.A :
polymorphonuclear leukocytes (PMNs); B: alveolar macrophages (AMs). Open columns - exposure with SWCNT (40 μg/mouse); gray columns -
exposure with CNF (120 μg/mouse); black columns - exposure with crocidolite asbestos (120 μg/mouse). Mice were exposed via pharyngeal
aspiration to doses indicated. Animals were sacrificed 1, 7, and 28 days post exposure. Average control (PBS-treated mice) values for PMNs (cells,
x10
3) on day 1, 7 or 28 post exposure were 1.58 ± 0.69, 1.39 ± 0.45 or 0.71 ± 0.24, respectively. Average control values for AMs (cells, x10
3)o n
day 1, 7 or 28 post exposure were 389.06 ± 22.80, 345.01 ± 30.01 or 229.79 ± 27.81, respectively. Means ± SE (n = 6 mice per group). *p < 0.05
vs. control mice,
ap < 0.05 vs. mice exposed to CNF,
bp < 0.05 vs. mice exposed to asbestos.
Figure 4 Pulmonary cell damage as evaluated by changes in LDH activity and air/blood barrier damage was evaluated by protein in the
bronchoalveloar lavage fluid of C57BL/6 mice in response aspiration of CNF, Crocidolite Asbestos or SWCNT.A :p r o t e i n ;B :L D H .O p e nc o l u m n s-
exposure with SWCNT (40 μg/mouse); gray columns - exposure with CNF (120 μg/mouse); black columns - exposure with crocidolite asbestos
(120 μg/mouse). Mice were exposed via pharyngeal aspiration to the doses indicated. Animals were sacrificed 1, 7, and 28 days post exposure. Average
control (PBS-treated mice) values for protein (mg/ml) on day 1, 7 or 28 post exposure were 0.31 ± 0.05, 0.33 ± 0.05 or 0.38 ± 0.05, respectively. Average
control values for LDH (U/ml) on day 1, 7 or 28 post exposure were 25.12 ± 0.70, 26.81 ± 1.03 or 25.47 ± 1.06, respectively. Means ± SE (n =6m i c ep e r
group). *p < 0.05 vs. control mice,
ap < 0.05 vs. mice exposed to CNF,
bp < 0.05 vs. mice exposed to asbestos.
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sure (120 μg/mouse) elicited a steady 1.8-fold increase in
protein carbonyls in the lungs of exposed mice (Figure
5B). Overall, SWCNT, CNF, and asbestos caused oxida-
tion of proteins in the lungs with the magnitude of the
oxidative damage as follows: SWCNT > CNF > asbestos.
Cytokines
Exposure to the studied NP resulted in accumulation of
pro-inflammatory cytokines in the mouse lungs (Figure 6).
The cytokine response peaked on day 1 post exposure to
SWCNT or CNF (Figure 6). On day 7 post-SWCNT or
CNF, levels of TNF-a and IL-10 remained significantly
elevated (2.5 and 0.8 fold of control, respectively) as com-
pared to controls (Figure 6A, F). In contrast, in asbestos-
exposed mice the release of inflammatory cytokines
peaked on day 7 post exposure (Figure 6).
TGF-b1, collagen deposition and morphometry
Significant elevation of TGF-b1 was found in BAL fluid
of mice after SWCNT, CNF or asbestos exposure
throughout the time course of the study (Figure 7A).
Maximal TGF-b1 release in BAL fluid of mice was
observed on day 7 post exposure. SWCNT induced the
higher release of TGF-b1o nd a y s1 ,7 ,a n d2 8p o s t
exposure (250, 450, and 125%, respectively, vs control),
with the highest level found on day 7, while exposure to
CNF or asbestos increased TGF-b1u pt om a x i m u mo f
200% of control on day 7. A pronounced collagen accu-
mulation was observed on day 28 post exposure in the
lungs of mice treated with CNF or asbestos (3 or 2.8
-fold vs control, respectively) (Figure 7B). SWCNT
exposure induced the most robust collagen buildup
reaching 5.8 fold increase comparing to controls. Mor-
phometric analysis of connective tissue stained with Sir-
ius Red is given in Figure 8A. Deposition of collagen
was observed in both granulomatous regions as well as
in the areas distant from granulomas in the lung of
mice exposed to SWCNT. This was established by con-
ventional light microscopy of lung sections specifically
stained with Sirius red (Figure 8E). The potency of
alveolar interstitial fibrosis was as follows: SWCNT >
CNF = asbestos (Figure 8).
Histopathology results
Histopathological changes in the lung of mice exposed to
CNF, SWCNT or asbestos were evaluated by a board-
certified veterinary pathologist. Representative micro-
graphs from each group are shown in Figure 9. A chronic
inflammatory reaction and fibrosis were observed 28 days
following NP exposure (Figure 9B-D). Fibrous connective
tissue was visualized in alveolar septa within the lungs of
animals exposed to SWCNT, CNF or asbestos. In con-
trast to CNF and asbestos, SWCNT exposure revealed
Figure 5 Biomarkers of oxidative stress in the lung of C57BL/6 Mice following aspiration with CNF, Crocidolite Asbestos, or SWCNT.A :
4-Hydroxynonenal; B: Protein Carbonyl. Mice were exposed via pharyngeal aspiration to the doses indicated. Open columns - exposure with
SWCNT (40 μg/mouse); gray columns - exposure with CNF (120 μg/mouse); black columns - exposure with crocidolite asbestos (120 μg/mouse).
Animals were sacrificed 1, 7, and 28 days post exposure. Means ± SE (n = 6 mice per group). *p < 0.05 vs. control (PBS) exposed mice;
ap < 0.05
vs. CNF exposed mice;
bp < 0.05 vs. asbestos exposed mice.
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Page 6 of 19granulomatous inflammation, with discrete granulomas
often surrounded by hypertrophied epithelioid macro-
phages associated with dense SWCNT agglomerates.
Interfacing bundles of fibrous connective tissue were
observed within discrete granulomas elicited by SWCNT
agglomerates (Figure 9D).
Proliferative response of splenic T cells from mice
exposed to SWCNT, CNF, or asbestos
To evaluate immune outcomes following exposure to
respirable SWCNT, CNF or asbestos, we assessed the
proliferative response of splenic T cells upon stimulation
with concavalin A (T cell mitogen). No significant
changes in proliferative response of splenic T cells from
animals exposed to CNF were observed on day 7 post
exposure, however a decreased proliferation was seen on
day 28 post exposure. We found a decrease in prolifera-
tion of splenic T-cells obtained from SWCNT-exposed
animals (~15% decrease vs control) on day 7 post
exposure; however, it was returned to control values
after 28 days. In contrast to CNF or SWCNT-treated
mice, spleen T cells obtained from asbestos-treated ani-
mals showed an increased proliferative response on day
7 post exposure as compared to controls, while on day
28 we observed a decrease in responsiveness of the T
cells to concavalin A (Figure 10).
Correlation between effective surface area of
nanomaterials administered and pulmonary outcomes
Pearson’s correlation coefficients were calculated for
pairs of variables including NM dose, expressed as spe-
cific surface area (measured by BET, Figure 11A) or
effective surface area (calculated as shown in Figure 2A-
B) of NM per mouse (Figure 11B), and the relative
values of the respective pulmonary outcomes. Several
correlations with effective s u r f a c ea r e aw e r ef o u n dt ob e
statistically significant (P < 0.05), including PMN counts
and total protein on day 1 post- exposure in BAL fluid
Figure 6 Cytokine accumulation in bronchoaleolar lavage fluid of C57BL/6 mice following aspiration of CNF, Crocidolite Asbestos, or
SWCNT. A: TNF-a; B: MCP-1; C: IL-6; D: IL-12p70; E: IFN-g; F: IL-10. Open columns - exposure with SWCNT (40 μg/mouse); gray columns -
exposure with CNF (120 μg/mouse); black columns - exposure with crocidolite asbestos (120 μg/mouse). Mice were exposed via pharyngeal
aspiration to the indicated doses. Animals were sacrificed 1, 7, and 28 days post exposure. Means ± SE (n = 6 mice per group).*p < 0.05 vs.
control (PBS) exposed mice,
bp < 0.05 vs. mice exposed to asbestos.
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Page 7 of 19Figure 7 Fibrogenic response as assessed by cytokine release in BAL fluid and collagen accumulation in the lung of C57BL/6 mice
following CNF, Crocidolite Asbestos or SWCNT exposure. A: TGF-b; B: Total collagen measured on day 28 post exposure. Open columns -
exposure with SWCNT (40 μg/mouse); gray columns - exposure with CNF (120 μg/mouse); black columns - exposure with crocidolite asbestos
(120 μg/mouse). Mice were exposed via pharyngeal aspiration to the indicated doses and animals were sacrificed 1, 7, and 28 days post
exposure. Means ± SE (n = 6 mice per group). *p < 0.05 vs. control (PBS) exposed mice;
ap < 0.05 vs. mice exposed to CNF,
bp < 0.05 vs. mice
exposed to asbestos.
Figure 8 Morphometric changes (A) and Sirius red-stained lung sections (B-E) from C57BL/6 mice 28 days following exposure to CNF,
Crocidolite Asbestos or SWCNT. A: Collagen fiber content determined as average thickness of connective tissue; Inset: Granulomatous cellular
tissue; B: Control; C: CNF; D: Asbestos; E: SWCNT (Arrow indicate collagen accumulation). Mice were exposed via pharyngeal aspiration to 120 μg/
mouse CNF or Asbestos, or 40 μg/mouse SWCNT. Animals were sacrificed 28 days post exposure. Means ± SE (n = 6 mice per group). *p < 0.05
vs. control (PBS) exposed mice,
ap < 0.05 vs. mice exposed to CNF,
bp < 0.05 vs. mice exposed to asbestos.
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Page 8 of 19(Figure 11B). In contrast, no statistically significant cor-
relations were found between the specific surface area
and pulmonary outcomes (Figure 11A).
Discussion
Fibrous nanoparticles vary in length, shape, diameter,
surface area, density, purity, content of transition metals,
porosity and chirality. In aqueous milieu, carbonaceous
NM tend to agglomerate and are rarely present as single
entities [24]. In particular, aggregation/agglomeration of
airborne CNF and CNT was previously reported in a
series of field workplace studies [25-27]. In the current
study, SWCNT appeared mainly as agglomerated
structures composed of SWCNT bundled into ropes
ranging 65-150 nm in diameter (Figure 1C). CNF were
seen as agglomerates incorporating a few individual
fibers with lengths varying from 5 to 30 μm, and widths
within 80-160 nm range (Figure 1A). In contrast, asbes-
tos fibers (2-30 μm in length and 0.16-0.8 μm in width)
were mostly well dispersed with few detectable agglom-
erated structures (Figure 1B).
Pulmonary clearance of NM depends critically on
their size and shape. Biopersistent, high aspect ratio
fibers are recognized as a special hazard to the lungs.
However, particle-like agglomerated structures of thin-
ner CNT need to be distinguished from the fiber-like
Figure 9 Light micrographs of H&E-stained sections from lung of C57BL/6 mice 28 days following exposure to PBS (A), CNF (B),
Crocidolite Asbestos (C) or SWCNT (D). Mice were exposed via pharyngeal aspiration to 120 μg/mouse CNF or Asbestos, or 40 μg/mouse
SWCNT. Animals were sacrificed 28 days post exposure.
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fiber-like materials (asbestos, CNF, CNT), translocation
to other tissues is determined by their dimensions, with
the critical diameter < 0.4 μm and length < 10 μm[ 2 8 ] .
The particle/agglomerate size as well as surface chemis-
try may be a significant factor affecting and/or limiting
the recognition/engulfment of NM by alveolar macro-
phages [29,30]. Exposure of pulmonary cells (e.g. epithe-
lial cells, macrophages, dendritic cells) to NM/fibers
may ultimately lead to a broad variety of responses, ran-
ging from cell damage/death (cytotoxicity) to engage-
ment of intracellular signaling pathways facilitating the
release of inflammatory mediators. Inflammation in the
lung promotes myofibroblast recruitment and transfor-
mation, deposition of fibrin degradation products accel-
erating collagen production and pulmonary fibrosis.
However, the prevailing mechanisms driving the fibrosis
may be quite diverse for each particle/fiber. Previously,
two distinct SWCNT particle morphologies were seen
in SWCNT preparations employed for assessment of
effects of respirable CNT: agglomerates and dispersed
states [10]. Accordingly, two morphologically distinct
responses were detected in the lungs as early as 7 days
post exposure. Foci of granulomatous inflammation,
including discrete granulomas often surrounded by
hypertrophied epithelioid macrophages, were associated
with deposition of SWCNT agglomerates. The SWCNT
materials were clearly visualized within granulomatous
lesions interfacing bundles of fibrous connective tissue.
In lung regions distant from observed SWCNT agglom-
erates, morphological alterations were predominantly
comprised of diffuse interstitial fibrosis with alveolar
wall thickening. This interstitial fibrosis occurred at sites
of deposition of more dispersed SWCNT structures
[31]. Importantly, deposition of collagen and elastin was
also observed in both granulomatous regions as well as
in the alveolar walls [10]. In the current study, asbestos
fibers did not form agglomerates in either of the aqu-
eous preparation, (Figure 1B) or as deposited within the
lungs of exposed animals (data not shown), while CNF
fibers formed loosely packed agglomerates in both sus-
pensions and in the lungs. The stiffness/rigidity of CNT
or CNF could certainly have an impact on the agglom-
eration propensity and interactions of these materials
with biological systems, and this has been the focus of
several recent studies [32,33]. In the present study, we
Figure 10 Splenic T Cell Proliferation 7 and 28 days following pulmonary exposure to CNF, Crocidolite Asbestos or SWCNT. Mice were
exposed via pharyngeal aspiration to 120 μg/mouse CNF or Asbestos, or 40 μg/mouse SWCNT. Animals were sacrificed 7 and 28 days post
exposure (white and black bars, respectively) and splenic T cell proliferation was evaluated. Means ± SE (n = 6 mice per group). *p < 0.05 vs.
control (PBS) exposed mice.
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and CNF tend to agglomerate, and such agglomerates
would no longer obey the rules of non-agglomerating
asbestos fibers. Therefore, interactions of agglomerated
CNP with biological systems would be defined by the
relative proportions of individual fibers vs. agglomerates
present. In particular, no granuloma formation was
found following exposure to fiber-like CNF particles/
agglomerates or asbestos (Figure 9B, C). Therefore,
granulomatous lesions formed after SWCNT exposure
may be attributed to specific scaffolding features of
SWCNT agglomerates. Here we demonstrate that
SWCNT agglomerates induce granuloma formation,
leading to morphological/structural isolation of SWCNT
agglomerates within the lung, presumably making them
less damaging to the surrounding pulmonary tissues.
Agglomerated SWCNT in the lungs, once walled off by
cuboidal cells, are less likely to cause acute inflamma-
tory reactions. Thus, relatively rapid isolation of
SWCNT aggregates/agglomerates within granulomas,
not observed upon exposure to CNF or asbestos, may
contribute to faster resolution of acute SWCNT-induced
neutrophilic inflammation and pneumonia (Figure 3A).
In addition, the potency for induction of alveolar inter-
stitial fibrosis was as follows: SWCNT > CNF = asbestos
(Figure 8A). Asbestos fibers are known to induce “fru-
strated phagocytosis” causing prolonged oxidative stress.
However, no frustrated phagocytosis was seen following
exposure of murine or human pulmonary phagocytes to
SWCNT [30,34]. The relatively large calculated effective
surface area of SWCNT (138 m
2/g vs 21 and 8.3 m
2/g
for CNF and asbestos, respectively) aids to the adhesion
of cell/tissue proteins to the surface of SWCNT [30,35].
In particular, the ability of SWCNT to serve as a scaf-
fold is beneficial for the adhesion and proliferation of
fibroblasts in the lungs and may be essential for their
sturdy fibrogenic potential [36]. The unique surface
structure of the SWCNT agglomerates and potential
affinity to lipid and protein covalent binding and coating
provides excellent environment facilitating growth and
proliferation of fibroblasts [37]. It is noteworthy that
CNF utilized in the current study share several physical
properties with MWCNT, such as a relatively large dia-
meter (as compared to SWCNT) which may contribute
to higher stiffness, less “tangling” and lower agglomera-
tion propensity for CNF as compared to SWCNT.
Recently, MWCNT have been reported to elicit “asbes-
tos-like” pathogenicity in rodent models, including lung
injury and mesothelioma formation [32,33]. In the cur-
rent study, we showed that the sub-acute inflammatory,
Figure 11 Correlation between specific surface area or effective surface area of nanomaterials administered and pulmonary outcomes
in the lung. (A) Correlation between specific surface area of NM administered (as measured by BET) and pulmonary outcomes in the lung
following exposure to Crocidolite Asbestos, CNF, or SWCNT on day 1 post exposure. Pearson’s correlation coefficients were calculated for pairs of
variables including NM dose (expressed as specific surface area of NM per mouse) and the relative values of the respective pulmonary outcomes:
♦ - NM dose, m
2/mouse; ■ - alveolar wall thickness, day 28 post exposure (r = 0.995, p > 0.05); ▲ - 4-HNE, day1 post exposure (r = 0.837, p >
0.05; × - PMN counts, day1 post exposure (r = 0.908, p > 0.05); ✱ - IL-6, day1 post exposure (r = 0.733, p > 0.05); ￿ - BAL protein, day1 post
exposure (r = 0.979, p > 0.05). (B) Correlation between effective surface area of NM administered and pulmonary outcomes. Pearson’s correlation
coefficients were calculated for pairs of variables including NM dose (expressed as effective surface area of NM per mouse) and the relative
values of the respective pulmonary outcomes: ♦ - NM dose, m
2/mouse; ■ - alveolar wall thickness, day 28 post exposure (r = 0.963, p > 0.05);
▲ - 4-HNE, day1 post exposure (r = 0.974, p > 0.05; × - PMN counts, day1 post exposure (r = 0.997, p < 0.05); ✱ - IL-6, day1 post exposure (r =
0.905, p > 0.05); ￿ - BAL protein, day1 post exposure (r = 0.997, p < 0.05).
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exposure to CNF are similar to asbestos. The carcino-
genic potential of CNF as well as other relatively long-
term outcomes is a matter for future investigations. Our
data showed that agglomerated SWCNT and CNF do
not behave as single, fibrous entities but rather as
agglomerated particles, and subsequently do not follow
the HARN paradigm. As demonstrated by Wang et al.
[38], SWCNT directly stimulate fibroblast proliferation
and collagen production in a cell culture system - in
line with the known fact that lung fibroblasts like to
grow upon SWCNT. This effect does not involve fru-
strated phagocytosis, as macrophages were not present
in the system, but appears to involve the activation of
matrix metalloproteinases (MMPs). It was recently
shown that up-regulation of MMP-12 and cathespin K
by SWCNT in co-culture of epithelial/mesenchymal
lung cells and BAL macrophages was due to cell-type
specific interactions [39]. The mechanisms of MMPs
activation in response to SWCNT - known to cause the
formation of irreversible interstitial fibrosis with airway
alteration and changes in pulmonary functions found in
mice [10,40,41] - resembled those that play a pivotal
role in the pathogenesis of idiopathic fibrosis and
obstructive airway disease in humans [42].”
Along with shape, size and structure, chemical composi-
tion of NM may also contribute to the inflammatory and
toxic outcomes. SWCNT and CNF are produced predomi-
nantly by HiPco, chemical vapor deposition, laser ablation
and arc discharge techniques involving utilization of var-
ious transition metal catalysts [43]. Catalytically competent
metal-containing NM may synergistically enhance oxida-
tive stress damaging the cells and tissues [34]. Kagan et al.,
[34] was one of the first to document - using EPR spectro-
scopy of ascorbate radicals as well as adducts with a spin-
trap, 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) - the pro-
duction of hydroxyl radicals generated by iron admixtures
in unpurified SWCNT as well as the suppression of these
signals by an iron chelator, desferroxamine. SWCNT, CNF
and asbestos employed in the current study were found to
have 0.23, 1.4, and 18% iron, respectively. Iron content of
unpurified SWCNT was previously implicated in
enhanced oxidative stress, depletion of antioxidant
reserves and accumulation of lipid peroxidation products
after SWCNT exposures. Neither Fe-rich (unpurified) nor
purified SWCNT were able to induce intracellular produc-
tion of superoxide or nitric oxide by RAW 264.7 macro-
phages [34]. Instead, extracellularly generated highly
reactive hydroxyl radicals, particularly in the presence of
Fe-rich SWCNT, were reported to enhance the oxidative
burst and cause oxidative stress via extracellular oxidation
[34]. One should, however, keep in mind that SWCNT
and CNF synthesized by high-pressure CO conversion
(HipCo) or CVD methodology results in accumulation of
mostly elemental iron embedded in the core crystalline
structure of CNP and thereby not readily mobilized in
water in ionic redox-active form. It is likely that uptake by
professional phagocytes whereby SWCNT may be loca-
lized in acidic environments of phago-lysosomes will lead
to the release of ionic iron, hence cause the toxic effects.
This secondarily ionized form of iron may be involved in
redox-cycling mechanisms and facilitate the development
of oxidative stress. However, the significance of this oxida-
tive stress for triggering non-specific peroxidation reac-
tions is likely limited. In fact, mass-spectrometry based
global lipidomics analysis of pulmonary lipid peroxidation
after the inhalation exposure of mice to iron-rich SWCNT
revealed a highly selective non-random pattern of phos-
pholipid peroxidation whereby only anionic phospholipids
cardiolipin, phosphatidylserine and phosphatidylinositol
underwend oxidative modification [44]. These data are in
sharp contrast with the expected random profile of peroxi-
dation of the most abundant polyunsaturated species of
phosphatidylcholine and phosphatidylethanolamine
observed during non-selective transition metal-catalyzed
peroxidation of phospholipids in tissues. In the current
study, exposure to SWCNT, CNF and asbestos resulted in
increased accumulation of biomarkers of oxidative stress,
e.g. 4-hydroxynonenal (4-HNE) and protein carbonyls
found in mouse lungs (Figure 5). Elevated levels of 4-HNE
were found on days 1, 7 and 28 in SWCNT or CNF -trea-
ted animals, in contrast to the peak seen on day 28 in
asbestos-treated mice (28 d). The most prominent induc-
tion of oxidative stress (4-HNE and protein carbonyls)
occurred after SWCNT-exposure. We speculate that the
relatively high surface area of carbonaceous NM facilitates
the efficient interactions of catalytically active Fe with cel-
lular components and pulmonary tissues; thereby explain-
ing why SWCNT elicited the most pronounced oxidative
stress, cell damage, granulomatous inflammation and
fibrosis.
Inflammatory milieu in the lung launches a wide variety
of signaling events engaging innate immunity and govern-
ing systemic/adaptive immune response. The pulmonary
innate immune system provides rapid recognition of
inhaled agents while orchestrating defensive responses.
Exposure to airborne NM could engage pulmonary innate
immunity at many levels. A number of recent publications
have reported the effects of carbonaceous NM on the
immune system [45-47]. It has been shown that splenic T
cell dysfunction and impaired systemic immunity was
associated with release of TGF-b and subsequent expres-
sion of IL-10 and PGE2 in the spleen [46]. Here, we
observed that SWCNT elicited the most prominent release
of TGF-b as compared to CNF and asbestos. Increased
TGF-b found in BAL on day 7 post exposure to SWCNT
was accompanied by slightly suppressed spleen T cell pro-
liferation. At this time-point, release of TGF-b in response
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to that of SWCNT. Exposure to CNF or asbestos, in con-
trast to SWCNT, did not suppress T cell proliferation on
day 7. Surprisingly, a slight stimulation of the spleen T cell
responsiveness was observed on day 7 in animals exposed
to asbestos (Figure 10). This stimulation may be partially
attributable to a marked increase in IL-12 in the lung
(Figure 6). However, 28 days post exposure, spleen T cell
proliferation was suppressed in both CNF and asbestos
treated animals, while pulmonary levels of TGF- b were
not markedly changed. These data suggest that splenic
T cell suppression at later time points (28 days) is not
likely due to TGF- b release. CNF appears to have effects
similar to asbestos causing a “delayed” immune suppres-
sion, which occurred when the acute inflammation was
resolved. It has been reported that asbestos-related
immune suppression followed 3 and 6 months after asbes-
tos instillation [48]. One could expect that SWCNT with
the highest surface area (138 m
2/g) would elicit the stron-
gest acute inflammation and release of TGF-b,a sc o m -
pared to CNF (21 m
2/g) and asbestos (8.3 m
2/g). At
equivalent mass doses, CNF and asbestos are generally less
capable of inducing TGF-b release in the lung; therefore,
the peripheral tolerance/suppression observed is most
likely driven by different mechanisms possibly involving
suppressive antigen presenting cells (APC) [46] and regu-
latory T cell induction.
In order to address whether specific surface area and/
or particle number derived from toxicological studies is
useful as a dose metric for hazard identification and risk
assessment, we attempted to correlate the inflammatory
(PMN) responses observed in the lungs of mice to either
specific surface area (measured by BET) or number of
particles/agglomerates in the given amount (mass) of
N M( F i g u r e1 1 A ) .T h ed o s eo fS W C N Tg i v e nt oa n i -
mals (40 μg/mouse) was equivalent to the specific sur-
face area of SWCNT of 4.16 × 10
-2 m
2/mouse, while
CNF and asbestos doses (120 μg/mouse) were equal to
5.4 × 10
-3 m
2/mouse and 9.6 × 10
-4 m
2/mouse, respec-
tively. The data presented in Figure 11 indicate that
although the specific surface area of SWCNT (measured
by BET) given to mice was 43 times higher as compared
to asbestos, PMN counts in BAL fluid of mice exposed
to SWCNT were only 5.7 fold higher (1 day post expo-
sure). Moreover, on day 7 post exposure PMN counts in
animals exposed to asbestos were 12.2 fold higher as
compared to SWCNT. Accordingly, particle number
alone does not seem to be a reliable factor in dose
metrics for assessment of NM exposure outcomes. At
the same concentration, SWCNT and CNF suspensions
had a much lower number of particles/structures due to
agglomeration as compared to non-agglomerated asbes-
tos (Figure 1D); however, the neutrophilic infiltration in
the lung of animals expos e dt oS W C N Ta n dC N Fw a s
greater as compared to asbestos-exposed mice (24 h
post exposure). These data suggest that specific surface
area (measured by BET) or particle/agglomerate num-
bers do not provide a reliable basis for predicting biolo-
gical outcomes of exposure to carbonaceous NM and is
therefore not an efficient dose metric for the assessment
of pulmonary outcomes in response to agglomerating
fibrous NM.
Indeed, PMN counts in BAL fluid of mice exposed to
SWCNT or CNF were increased by ~5.7 and ~2.8 fold,
respectively, as compared to asbestos. Of note, the calcu-
lated effective surface areas of SWCNT and CNF agglom-
erates delivered to the lung were ~5.8- and ~2.6- fold
higher (vs. asbestos, respectively, day 1 post exposure).
Correlations between various pulmonary outcomes and
effective surface area of NM administered to the animals
are presented on Figure 11. Protein levels in BAL fluid of
mice exposed to NM (day 1 post exposure) were well cor-
related with the calculated effective surface area of particle
agglomerates given to animals: Pearson’s correlation coef-
ficient was 0.997, p < 0.05. Additionally, our data suggests
that the high aspect ratio nanoparticle (HARN) paradigm
[49] is not fully applicable for the assessment of the hazar-
dous effects of carbonaceous fibrous NM. Therefore, in
addition to mass dose, the effective surface area of NM
structures should be experimentally determined by
detailed analysis of NM agglomerates. Effective surface
area of NP agglomerates may be useful as a predictive
dose metric of pulmonary toxicity - acute inflammation,
pulmonary damage and fibrosis - induced by SWCNT or
CNF and could thus be utilized for health hazard and risk
assessment of fibrous carbonaceous NM.
Conclusions
1. CNF, SWCNT and asbestos cause inflammation, pul-
monary damage and fibrosis in the lung of mice with the
following mass-based potency: SWCNT > CNF ≥ asbes-
tos. Early and robust fibrosis elicited by SWCNT may be
partially attributed to scaffolding properties of SWCNT.
2. Exposure to SWCNT, CNF and asbestos resulted in
oxidative stress in the lung. Despite the higher iron con-
tent in asbestos, SWCNT and CNF caused more severe
oxidative stress/damage as compared to asbestos.
3. SWCNT, CNF and asbestos were able to modulate
local and systemic immunity upon pulmonary exposure.
At equivalent mass doses, CNF and asbestos are gener-
ally less capable of inducing suppressive TGF-b1 release
in the lung; therefore, the peripheral tolerance/suppres-
sion observed is most likely driven by mechanisms
involving APC such as DCs.
4. It is questionable if agglomerated SWCNT and CNF
structures can be considered conventional fibers; hence,
their effects may not be readily understood according to
the HARN paradigm.
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necessarily predict biological/toxicological responses to
carbonaceous fibrous NM in living organisms, and
therefore are not - according to the present data - the
most appropriate dose metric for agglomerating NM.
6. Values of effective calculated surface area of
agglomerated NM could be useful for prediction of bio-
logic responses e.g. pulmonary inflammation, damage
and fibrosis.
Materials and methods
Animals
Specific pathogen-free adult female C57BL/6 mice (8-10
wk) were supplied by Jackson Lab (Bar Harbor, ME)
and weighed 20.0 ± 1.9 g when used. Animals were
housed one mouse per cage receiving HEPA filtered air
in the AAALAC-accredited NIOSH animal facilities. All
animals were acclimated in the animal facility under
controlled temperature and humidity for one week prior
to use. Beta Chips (Northeastern Products Corp., War-
rensburg, NY) were used for beddings and changed
weekly. Animals were supplied with water and certified
chow 7913 (Harlan Teklad, Indianapolis, IN) ad libitum,
in accordance with guidelines and policy set forth by
the Institute of Laboratory Animals Resources, National
Research Council. All experimental procedures were
conducted in accordance with a protocol approved by
the NIOSH Institutional Animal Care and Use
Committee.
Experimental design
A suspension of SWCNT (40 μg/mouse), CNF (120 μg/
mouse) or asbestos (120 μg/mouse) was used for single
pharyngeal aspiration of C57BL/6 mice, while the corre-
sponding control mice were administered sterile Ca
+2 +
Mg
+2-free phosphate-buffered saline (PBS) vehicle. Mice
were sacrificed on days 1, 7 and 28 following exposure.
All experiments were repeated at least three times.
Inflammation was evaluated by total cell counts, cell dif-
ferentials, and accumulation of cytokines in the bronch-
oalveolar lavage (BAL) fluid. Pulmonary toxicity was
assessed by elevation of LDH activity in acellular BAL
fluid. Fibrogenic responses to exposed materials were
assessed by alveolar wall thickness morphometry and
collagen deposition. For each group six animals were
used to do BAL analysis, histopathology evaluation, oxi-
dative stress markers, and lung collagen measurement.
Particles
CNF were obtained from Pyrograf Products, Inc. Carbon
nanofibers were vapor grown (PR-24, LHT grade) and
heat treated (up to 3000°C) to graphitize chemically
vapor deposited carbon present on the surface of the
pyrograf and to remove iron catalyst. SWCNT (Unidym
Inc, Sunnyvale, CA) were manufactured using the high
pressure CO disproportionation process (HiPco™)a n d
purified with acid treatment to remove catalytic metal
contaminants [50]. An UICC standard crocidolite asbes-
tos was utilized for comparison of fiber effects. Total
elemental carbon and trace metal analysis was per-
formed by the Chemical Exposure and Monitoring
Branch (DART/NIOSH, Cincinnati, OH). Elemental car-
bon was assessed according to the NIOSH Manual of
Analytical Methods (NMAM) [51], while trace metal
were analyzed by nitric acid dissolution and inductively
coupled plasma-atomic emission spectrometry (ICP-
AES) following NMAM method 7300 for trace metals.
Raman spectroscopy, near-infrared (NIR) spectroscopy,
and thermo-gravimetric analysis (TGA) were used for
purity assessment of HiPco™ SWCNT. Specific surface
area was measured at -196°C by the nitrogen absorp-
tion-desorption technique (Brunauer Emmet Teller
method, BET) using a SA3100 Surface Area and Pore
Size Analyzer (Beckman Coulter Inc, Fullerton, CA),
and diameter was measured by TEM. For all size distri-
bution measurements and animal exposures, divalent
ion free PBS was utilized as a particle dispersion med-
ium. Prior to animal exposure or size measurements,
particles were ultrasonicated (30s × 3 cycles) for
improved dispersion of nanoparticles using Vibra Cell
(Sonics and Materials Inc., CT, USA) probe sonicator
operating at 20 kHz (65% power).
Particle imaging and size measurements
Images of NP suspensions were obtained by field emis-
sion scanning electron microscopy. The size distribution
of samples, including agglomerate measurements, were
performed as previously described by Wang et al. [52].
In brief, the particles deposited on polycarbonate filter
were viewed under a field emission scanning electron
microscope (model S-4800; Hitachi, Tokyo, Japan) at
400 and 30,000 magnifications. The average length and
width of the structures in each sample were determined
by analysis of a minimum of 300 particles. Number con-
centrations of structures were estimated by analyzing 10
fields of view for every particle type/suspension.
Agglomerates were counted as a single entity.
Particulate instillation
Mouse pharyngeal aspiration was used for particulate
administration. Briefly, after anesthetization with a mix-
ture of ketamine and xylazine (62.5 and 2.5 mg/kg sub-
cutaneous in the abdominal area), the mouse was placed
on a board in a near vertical position and the animal’s
tongue extended with lined forceps. A suspension
(approximately 50 μl) of SWCNT (40 μg/mouse), CNF
(120 μg/mouse), or asbestos (120 μg/mouse) prepared in
divalent ion free PBS was placed posterior on the throat
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aspirated into the lungs. Control mice were adminis-
tered sterile Ca
+2 +M g
+2-free phosphate-buffered saline
(PBS) vehicle. The mice revived unassisted after approxi-
mately 30-40 min. All mice in PBS, SWCNT, CNF, and
asbestos groups survived this exposure procedure. This
technique provided good distribution of particles widely
disseminated in a peri-bronchiolar pattern within the
alveolar region as was detected by histopathology [53].
Animals treated with the particulates and PBS recovered
easily after anesthesia with no behavioral or negative
health outcomes. Mice were sacrificed on days 1, 7, and
28 days following the exposure.
Estimation of effective surface area from geometric
analysis of SWCNT and CNF’s
The theoretical effective surface area (ESA) was esti-
mated based on the geometrical analysis of carbon
nanotubes and nanofibers, using the CNT surface area
models developed previously [54]. Assuming that both
CNT’sa n dC N F ’s are generated from the base material
graphene, the ESA of SWCNT bundle can be estimated
as the product of specific surface area (SSA) of graphene
(in m
2/g) and the effective surface area of a N layered
SWCNT bundle. The SSA of a graphene was estimated
as 1315 m
2/g. The effective surface area(Neq-ssa)o fN
layered (NL) SWCNT bundle can be obtained using the
ratio between the number of individual SWCNT with a
total accessible surface area equal to that of a bundle
made up of N SWCNT and the total number of
SWCNT’s (N) in a bundle. The parameters NL,N eq-ssa
and N of a bundle can be estimated as follows:
NL =0 . 5×

diameter of the bundle/diameter of SWCNT

− 0.5 (1)
Neq−ssa = (3 × NL) +1 (2)
N = 6.3791 × NL
(1..6646) (3)
ESA(bundle) = SSA of graphene ×

Neq−ssa/N

=1 3 1 5×

Neq−ssa/N
 (4)
In order to estimate the ESA of CNFs, we assumed
the concentric graphitic sheets of CNFs are approxi-
mately similar to the model of MWNT proposed by
Peigney et al. [54]. To calculate thickness of the walls
and number of carbon layers of CNF in our study, we
determined the average diameter of the hollow core
(dHC) and outer diameters (dOD) of the CNF based on
the SEM images taken (Figure 1A). Assuming that the
inter-wall distance between any two carbon layers is
0.34 nm, number of layers (n-layers) in a CNF and ESA
of CNF can be estimated using the following equations.
n − layers = ((dOD) − (dHC))/(2 × 0.34) (5)
ESA(CNF) =

SSA of graphene × (dOD)

/

n − layers × (dOD)

−−

2 × 0.34 ×
n−1 
i=1
i

(6)
Obtaining bronchoalveolar lavage (BAL) from mice
Mice were weighed and sacrificed with intraperitoneal
injection of sodium pentobarbital (> 100 mg/kg) and
exsanguinated. The trachea was cannulated with a
blunted 22 gauge needle, and BAL was performed using
cold sterile PBS at a volume of 0.9 ml for first lavage
(kept separate) and 1.0 ml for subsequent lavages.
Approximately 5 ml of BAL fluid per mouse was col-
lected in sterile centrifuge tubes. Pooled BAL cells for
each individual mouse were washed in PBS by alternate
centrifugation (800 ×g for 10 min at 4°C) and resuspen-
sion. Cell-free first fraction BAL aliquots were stored at
4°C for LDH assays while the remainder was frozen at
-80°C until processed.
BAL cell counting and differentials
The degree of inflammatory response induced by phar-
yngeally aspirated SWCNT, CNF or asbestos was esti-
mated by quantitating total cells, alveolar macrophages
(AMs), and polymorphonuclear leukocytes (PMNs)
recovered by BAL. Cell counts were performed using an
electronic cell counter equipped with a cell sizing
attachment (Coulter model Multisizer II with a 256 C
channelizer, Coulter Electronics, Hialeah, FL). Alveolar
macrophages (AM), and PMNs, were identified by their
characteristic cell shape in cytospin preparations stained
with Diffquick (Fisher Scientific, Pittsburgh, PA), and
differential counts of BAL cells were carried out. Three
hundred cells per slide were counted.
Total protein and lactate dehydrogenase (LDH) activity in
the BAL fluid
Measurement of total protein in the BAL fluid was per-
formed by a modified Bradford assay according to the
manufacturer’s instructions (BioRad, Hercules, CA) with
bovine serum albumin as a standard. The activity of LDH
was assayed spectrophotometrically by monitoring the
reduction of nicotinamide adenine dinucleotide at 340
nm in the presence of lactate using Lactate Dehydrogen-
ase Reagent Set (Pointe Scientific, Inc., Lincoln Park, MI).
Lung lavage fluid cytokine analysis
Levels of cytokines were assayed in the acellular BAL
fluid following SWCNT, CNF or asbestos aspiration.
The concentrations of TNF-a, MCP-1, IL-12, IL-6, IL-
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determined using the BD™ Cytometric Bead Array,
Mouse Inflammation kit (BD Biosciences, San Diego,
CA). The concentration of active TGF-b1, (sensitivity of
assay is < 15.6 pg/ml) was determined using an ELISA
kit (Biosource International Inc., Camarillo, CA).
Preparation of lung homogenates
The whole mouse lungs were separated from other tis-
sues and weighed before being homogenized with a tis-
sue tearer (model 985-370, Biospec Products Inc.,
Racine, WI) in PBS (pH 7.4) for 2 min. The homogenate
suspension was frozen at -80°C until processed.
Evaluation of biomarkers of oxidative stress in the lung
Oxidative damage to the lung following exposure to
CNF, SWCNT, or asbestos was evaluated by the pre-
sence of 4-hydroxynonenol (4-HNE) and protein carbo-
nyl formation. 4-HNE, a byproduct of lipid peroxidation,
was measured in lung homogenates by ELISA using the
OxiSelect HNE-His adduct kit (Cell Biolabs, Inc, San
Diego, CA). The quantity of oxidatively modified pro-
teins as assessed by measurement of protein carbonyls
in lung homogenates was determined using the Biocell
PC ELISA kit (Northwest Life Science Specialties). Sen-
sitivity of the assay is < 0.1 nmol/mg protein.
Lung preparation for microscopic evaluation
Preservation of the lung was achieved by vascular perfu-
sion with a glutaraldehyde (2%), formaldehyde (1%), and
tannic acid (1%) fixative with sucrose as an osmotic
agent [55]. This method of fixation was chosen to pre-
vent possible disturbances of the airspace distribution of
deposited materials while maintaining physiological
inflation levels comparable to that of the end expiratory
volume. This was performed using protocols previously
employed to study pulmonary effects of SWCNT [10].
Briefly, animals were deeply anesthetized with an over-
dose of sodium pentobarbital by subcutaneous injection
in the abdomen, the trachea was cannulated, and lapar-
otomy was performed. Mice were then sacrificed by
exsanguination. The pulmonary artery was cannulated
via the ventricle and an outflow cannula inserted into
the left atrium. In quick succession, the tracheal cannula
was connected to a 5 cm H2O pressure source, and
clearing solution (saline with 100 U/ml heparin, 350
mosM sucrose) was perfused to clear blood from the
lungs. The perfusate was then switched to the fixative.
Coronal sections were cut from the lungs. The lungs
were embedded in paraffin and sectioned at a thickness
of 5 μm with an HM 320 rotary microtome (Carl Zeiss,
Thornwood, NY). Lung sections for histopathological
evaluation were stained with hematoxylin and eosin and
examined by a board certified veterinary pathologist for
morphological alterations.
Lung collagen measurements
Total lung collagen content was determined by quantify-
ing total soluble collagen using the Sircol Collagen
A s s a yk i t( A c c u r a t eC h e m i c a l and Scientific Corpora-
tion, Westbury, NY). Briefly, whole lungs were homoge-
nized in 0.7 ml of 0.5 M acetic acid containing pepsin
(Accurate Chemical and Scientific Corporation, West-
bury, NY) with 1:10 ratio of pepsin: tissue wet weight.
Each sample was stirred vigorously for 24 h at 4°C, cen-
trifuged, and 200 μl of supernatant was assayed accord-
ing to the manufacturer’s instructions.
Morphometric evaluation Sirius red staining of lung
sections
The distributions of type I and III collagen in the lung
tissue were determined by morphometric evaluation of
the Sirius red-stained sections. Briefly, paraffin lung sec-
tions (5-μm thick) were deparaffinized and dehydrated.
To identify collagen fibers under the microscope, the
sections were stained with F3BA/picric acid for 1-2 h,
washed with 0.01 N HCl for 1 min, and counterstained
with Mayer’s hematoxylin for 2 min. The slides were
then dehydrated and mounted with a coverslip [56].
Type I and III collagen stained by Sirius red was visua-
lized, and six randomly selected areas were scored
under polarized microscopy using image analysis. With
this morphometric method, the average thickness of Sir-
ius red-positive connective tissues in the alveolar wall
was quantitatively measured. Volume and surface den-
sity were measured using standard morphometric ana-
l y s e so fp o i n t sa n di n t e r c e p tc o u n t i n g[ 5 7 ] .A v e r a g e
thickness of the Sirius red-positive connective tissues of
the alveolar wall was computed from two times the
ratio of volume density of points to the surface density
of the alveolar wall.
Spleen harvest and cell isolation
Spleens from C57BL/6 mice following exposure to PBS,
CNF, SWCNT, or asbestos were obtained on day 7 and
28 post exposure. Spleens were aseptically harvested
then ground and the suspension was filtered through a
cell strainer. Isolated splenocytes were then centrifuged
and red blood cells were lysedu t i l i z i n gr e db l o o dc e l l
lysing buffer (Sigma).
Splenocyte proliferation, ex vivo
Splenocytes were obtained from exposed (120 μg/mouse
CNF, asbestos or 40 μg/mouse SWCNT) or nonexposed
C57BL/6 mice (day 7 and 28 post exposure). Cells were
labeled with 5-(and-6)-carboxyfluorescein diacetate at
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CA), counted using a hemacytometer, diluted in com-
plete medium (1 × 10
6 cells/mL), and stimulated with 5
μg/mL concavalin A (Sigma, St. Louis, MO) for 4 days
in 24-well plates in triplicates. The proliferation
response was measured using flow cytometry (BD
FACSCalibur instrument, BD, NJ). Dead cells were
excluded from the assay with propidium iodide staining
preceding the flow cytometry. The background fluores-
cence readings were subtracted during the analysis. Pro-
liferation index is the average number of cell divisions
that the responding T cells underwent. Only responding
T cells are reflected in the proliferation index. The pro-
liferation indices were calculated from flow cytometry
data using the Flowjo software package (Tree Star Inc.,
Ashland, OR).
Statistics
Treatment related differences were evaluated using two-
way ANOVA, followed by pair wise comparison using
the Student-Newman-Keuls tests, as appropriate. Pear-
son’s correlation coefficients (r) were calculated for pairs
of variables including NP effective surface area and rela-
tive values of PMN, protein, 4-HNE, IL-6 and alveolar
wall thickness. The degrees of freedom (df) for correla-
tion calculations were considered 1. Statistical signifi-
cance was considered at p < 0.05. Data are presented as
Mean ± SE.
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